Group items tagged

A study has revealed that understanding the genetic and molecular structure of individual breast tumours could provide information on cancer progression and recurrence.

A pioneering study looking into the possibility of combining existing therapies to slow down cancer growth is showing encouraging early results. Elly Earls reports. A first-of-its-kind medical study at The Care Oncology Clinic on Harley Street, London, has started work on evaluating whether the use of a combination of safe, tolerable, existing, generic therapies could slow down cancer growth and improve survival times in patients for whom other treatments are no longer available or working.

Patrunjelul poate fi folosit ca un remediu pentru aceasta boala teribila,cancerul, datorita substantei apigenina , care distruge celulele canceroase de până la 86%.

US media said that it is well known that in some rare cases, organ transplants can cause infectious diseases to pass from donors to recipients. However, as a new case shows, even more so, organ transplantation can also lead to the spread of cancer. US Fun Science website on September 15, a new

AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.

Mesothelioma cancer affecting mesothelial cells that cover most internal organs. There are two main types of mesothelioma; pleura and peritoneum.

US-based medical technology firm iCAD is set to partner with two researchers at the Karolinska Institutet in Sweden on the development of an artificial intelligence (AI)-based system to detect individual risk of breast cancer development.

Paige.AI has received breakthrough device designation from the US Food and Drug Administration (FDA) for a cancer diagnosis solution based on artificial intelligence (AI).

It is over 200 years old and is a proven cure for many kinds of diseases including Heart disease, Diabetes, hypertension, Cholesterol and Cancer.

Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.

Liquid biopsy, a minimally invasive cancer diagnostic tool, has gained momentum in the last five years due to its advantages over the archaic painful procedure of solid tumour biopsy.

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study. By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.

Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.

CASH4NEEDS$CAMPAIGN BASE DESTROY HEALTH CARE SHORTFALL CANCER RESEARCH BASE ENERGY DRINKS PHOTO - BUZZEZESOCIAL.NING.COM THE ROCKETT 257 COMPANY INC. NEW AGE WAR MACHINE BUZZEZESOCIAL.NING.COM NEW PRIME BUSINESS: I Have Dropped Everything to get the Word OUT.New Global Curve,"Hemp Oil Products"currently 170 million,BUT,Forbes Projects,"Next Multi-Billion Dollar Industry"WHY,CBD,Cannabidiol The Super Ingredient in Hemp(NON THC) Natural Medicinal Health Benefits,Endless,CBD IS the Component in the Cannabis Family which is for Pain Relief.CTFO,Changing The Future Outcome Gives You a Free 70 Product E-Commerce Store with Shopping Cart,Unique 4 Money Stream Payment Plan,Get in the Forefront of this HUGE Health and Wellness Trend! http://buzzezesocial.ning.com/photo/photo/slideshow?albumId=2008828:Album:8303

Qiagen has launched the new therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for the detection of patients who could benefit from treatment with Swiss pharmaceutical company Novartis' new breast cancer drug, Piqray (alpelisib).

People can be at a loss for words when someone they know is diagnosed with a serious illness. Typical "get well soon"

The US Food and Drug Administration (FDA) has highlighted concerns about using robotically assisted surgical devices for mastectomies and other cancer surgeries, citing a lack of evidence for safety and effectiveness.